Moderna and Pfizer are reinventing vaccines, starting with covid

- The two leading Covid-19 vaccines are based on a new gene-based technology that could help fight a range of diseases
The strong early results for two leading Covid-19 vaccines have implications that go far beyond the current pandemic: They suggest the time has come for a gene-based technology that could provide new treatments for cancer, heart disease and other infectious diseases.